OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
33
Results
Show all
Save search
Copy query
Show results for
Unknown
(33)
Publication Date
Release Date
2023
(6)
2013
(4)
2022
(3)
2014
(3)
2011
(3)
2021
(2)
2016
(2)
2015
(2)
2012
(2)
2010
(2)
2009
(2)
2024
(1)
2008
(1)
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
Randomized, phase III trial of first-line figitumumab in combination with paclitaxel and carboplatin versus paclitaxel and carboplatin alone in patients with advanced non-small-cell lung cancer.
Not available
S-EPMC4067944
|
biostudies-literature
Cite
Subtype and Site Specific-Induced Metabolic Vulnerabilities in Prostate Cancer.
Not available
S-EPMC9812897
|
biostudies-literature
Cite
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
Not available
S-EPMC7787219
|
biostudies-literature
Cite
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.
Not available
S-EPMC8220996
|
biostudies-literature
Cite
Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S.
Not available
S-EPMC8849184
|
biostudies-literature
Cite
Genetic modifiers of liver disease in cystic fibrosis.
Not available
S-EPMC3711243
|
biostudies-literature
Cite
Observational study of the development of diabetic macular edema following panretinal (scatter) photocoagulation given in 1 or 4 sittings.
Not available
S-EPMC2754061
|
biostudies-literature
Cite
A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema.
Not available
S-EPMC2748264
|
biostudies-literature
Cite
Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction.
Not available
S-EPMC2911350
|
biostudies-literature
Cite
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion.
Not available
S-EPMC3306163
|
biostudies-literature
Cite
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets